The Precision Peptide Genetic Test reveals predispositions in GLP-1 receptor sensitivity, glucose-dependent insulinotropic polypeptide signaling, and appetite regulation pathways
They are not FDA-approved for weight loss
GLP-1 medications reduce appetite, but protein intake, resistance exercise, and hydration matter more while on the medication, not less, to protect lean muscle mass and keep side effects manageable
Some compounds primarily activate the GLP-1 receptor , while others simultaneously target GIP receptors , glucagon receptors , or amylin pathways
Orthostatic tachycardia : Some patients may experience an exaggerated heart rate increase upon standing, particularly if dehydrated